Details for New Drug Application (NDA): 203154
✉ Email this page to a colleague
The generic ingredient in ALLOPURINOL is allopurinol sodium. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.
Summary for 203154
Tradename: | ALLOPURINOL |
Applicant: | Accord Hlthcare |
Ingredient: | allopurinol |
Patents: | 0 |
Pharmacology for NDA: 203154
Mechanism of Action | Xanthine Oxidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 203154
Suppliers and Packaging for NDA: 203154
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALLOPURINOL | allopurinol | TABLET;ORAL | 203154 | ANDA | Accord Healthcare Inc. | 16729-134 | 16729-134-01 | 100 TABLET in 1 BOTTLE (16729-134-01) |
ALLOPURINOL | allopurinol | TABLET;ORAL | 203154 | ANDA | Accord Healthcare Inc. | 16729-134 | 16729-134-16 | 500 TABLET in 1 BOTTLE (16729-134-16) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | May 6, 2013 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
Approval Date: | May 6, 2013 | TE: | AB | RLD: | No |
Complete Access Available with Subscription